United Therapeutics (UTHR) Equity Ratio (2016 - 2025)
Historic Equity Ratio for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to 0.9.
- United Therapeutics' Equity Ratio rose 466.98% to 0.9 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.9, marking a year-over-year increase of 466.98%. This contributed to the annual value of 0.88 for FY2024, which is 479.23% up from last year.
- Per United Therapeutics' latest filing, its Equity Ratio stood at 0.9 for Q3 2025, which was up 466.98% from 0.91 recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Equity Ratio registered a high of 0.91 during Q2 2025, and its lowest value of 0.74 during Q1 2021.
- Its 5-year average for Equity Ratio is 0.82, with a median of 0.81 in 2023.
- In the last 5 years, United Therapeutics' Equity Ratio surged by 136.54% in 2021 and then surged by 704.96% in 2025.
- United Therapeutics' Equity Ratio (Quarter) stood at 0.77 in 2021, then increased by 3.61% to 0.79 in 2022, then rose by 5.23% to 0.84 in 2023, then increased by 4.79% to 0.88 in 2024, then rose by 2.45% to 0.9 in 2025.
- Its Equity Ratio stands at 0.9 for Q3 2025, versus 0.91 for Q2 2025 and 0.88 for Q1 2025.